Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Consensus statement of the Italian society of colorectal surgery (SICCR): management and treatment of hemorrhoidal disease.

Gallo G, Martellucci J, Sturiale A, Clerico G, Milito G, Marino F, Cocorullo G, Giordano P, Mistrangelo M, Trompetto M.

Tech Coloproctol. 2020 Feb;24(2):145-164. doi: 10.1007/s10151-020-02149-1. Epub 2020 Jan 28. Review.

PMID:
31993837
2.

Intracorporeal or Extracorporeal Ileocolic Anastomosis After Laparoscopic Right Colectomy: A Double-blinded Randomized Controlled Trial.

Allaix ME, Degiuli M, Bonino MA, Arezzo A, Mistrangelo M, Passera R, Morino M.

Ann Surg. 2019 Nov;270(5):762-767. doi: 10.1097/SLA.0000000000003519.

PMID:
31592811
3.

Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy.

Parasiliti-Caprino M, Lucatello B, Lopez C, Burrello J, Maletta F, Mistrangelo M, Migliore E, Tassone F, La Grotta A, Pia A, Reimondo G, Giordano R, Giraudo G, Piovesan A, Ciccone G, Deandreis D, Limone P, Orlandi F, Borretta G, Volante M, Mulatero P, Papotti M, Aimaretti G, Terzolo M, Morino M, Pasini B, Veglio F, Ghigo E, Arvat E, Maccario M.

Hypertens Res. 2019 Oct 4. doi: 10.1038/s41440-019-0339-y. [Epub ahead of print]

PMID:
31586159
4.

Individual participant data pooled-analysis of risk factors for recurrence after neoadjuvant radiotherapy and transanal local excision of rectal cancer: the PARTTLE study.

Arezzo A, Lo Secco G, Passera R, Esposito L, Guerrieri M, Ortenzi M, Bujko K, Perez RO, Habr-Gama A, Stipa F, Picchio M, Restivo A, Zorcolo L, Coco C, Rizzo G, Mistrangelo M, Morino M.

Tech Coloproctol. 2019 Sep;23(9):831-842. doi: 10.1007/s10151-019-02049-z. Epub 2019 Aug 6.

PMID:
31388861
5.

Practice parameters for the diagnosis and treatment of anal intraepithelial neoplasia (AIN) on behalf of the Italian Society of Colorectal Surgery (SICCR).

Binda GA, Gagliardi G, Dal Conte I, Verra M, Cassoni P, Cavazzoni E, Stocco E, Delmonte S, De Nardi P, Sticchi L, Mistrangelo M.

Tech Coloproctol. 2019 Jun;23(6):513-528. doi: 10.1007/s10151-019-02019-5. Epub 2019 Jun 26.

PMID:
31243606
6.

The Role of High-resolution Anoscopy and Random Biopsies: The Role of Infrared Coagulation vs Active Monitoring in the Treatment of High-grade Squamous Intraepithelial Lesions.

Mistrangelo M, Dal Conte I.

Clin Infect Dis. 2020 Feb 14;70(5):987. doi: 10.1093/cid/ciz487. No abstract available.

PMID:
31180466
7.

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier).

Casadei-Gardini A, Montagnani F, Casadei C, Arcadipane F, Andrikou K, Aloi D, Prete AA, Zampino MG, Argentiero A, Pugliese G, Martini S, Iorio GC, Scartozzi M, Mistrangelo M, Fornaro L, Cassoni P, Marisi G, Dell'Acqua V, Ravenda PS, Lonardi S, Silvestris N, De Bari B, Ricardi U, Cascinu S, Franco P.

Cancer Manag Res. 2019 Apr 26;11:3631-3642. doi: 10.2147/CMAR.S197349. eCollection 2019. Erratum in: Cancer Manag Res. 2019 Jun 25;11:5123.

8.

Progression of LSIL to HSIL or SCC: is anoscopy and biopsy good enough?

Mistrangelo M, Salzano A.

Tech Coloproctol. 2019 Apr;23(4):303-304. doi: 10.1007/s10151-019-02001-1. Epub 2019 May 18. No abstract available.

PMID:
31104190
9.

Toward uniform and controlled clinical pathways in cancer care: a qualitative description.

Numico G, Viale M, Bellini R, Ippoliti R, Rossi M, Maan T, Carobene A, Pizzini A, Mistrangelo M, Bertetto O.

Int J Qual Health Care. 2019 Feb 26. pii: mzz015. doi: 10.1093/intqhc/mzz015. [Epub ahead of print]

PMID:
30809643
10.

[Lifestyle, risk factors and prevention of cancer: role of the cardiologist].

Abrignani MG, Parrini I, Grosseto D, Lestuzzi C, Mistrangelo M, Passaretti B; a nome dell'Area Prevenzione Cardiovascolare ANMCO e della Task Force Cardioncologia ANMCO.

G Ital Cardiol (Rome). 2019 Jan;20(1):20-31. doi: 10.1714/3079.30717. Review. Italian.

PMID:
30638212
11.

Preoperative stoma site marking: a simple practice to reduce stoma-related complications.

Arolfo S, Borgiotto C, Bosio G, Mistrangelo M, Allaix ME, Morino M.

Tech Coloproctol. 2018 Sep;22(9):683-687. doi: 10.1007/s10151-018-1857-3. Epub 2018 Sep 28.

PMID:
30267265
12.

Intraoperative air leak test reduces the rate of postoperative anastomotic leak: analysis of 777 laparoscopic left-sided colon resections.

Allaix ME, Lena A, Degiuli M, Arezzo A, Passera R, Mistrangelo M, Morino M.

Surg Endosc. 2019 May;33(5):1592-1599. doi: 10.1007/s00464-018-6421-8. Epub 2018 Sep 10.

PMID:
30203203
13.

Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study.

Franco P, De Bari B, Arcadipane F, Lepinoy A, Ceccarelli M, Furfaro G, Mistrangelo M, Cassoni P, Valgiusti M, Passardi A, Casadei Gardini A, Trino E, Martini S, Iorio GC, Evangelista A, Ricardi U, Créhange G.

Radiat Oncol. 2018 Sep 10;13(1):172. doi: 10.1186/s13014-018-1124-9.

14.

Dose to Pelvic Bone Marrow Defined with FDG-PET Predicts for Hematologic Nadirs in Anal Cancer Patients Treated with Concurrent Chemo-radiation.

Franco P, Arcadipane F, Ragona R, Lesca A, Gallio E, Mistrangelo M, Trino E, Cassoni P, Arena V, Baccega M, Racca P, Faletti R, Rondi N, Morino M, Ricardi U.

Cancer Invest. 2018;36(5):279-288. doi: 10.1080/07357907.2018.1479413. Epub 2018 Jun 28.

PMID:
29953269
15.

Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter Study.

Gallo G, Mistrangelo M, Passera R, Testa V, Pozzo M, Perinotti R, Lanati I, Lazzari I, Tonello P, Ugliono E, De Luca E, Realis Luc A, Clerico G, Trompetto M.

Gastroenterol Res Pract. 2018 Mar 19;2018:6423895. doi: 10.1155/2018/6423895. eCollection 2018.

16.

The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer.

Franco P, Montagnani F, Arcadipane F, Casadei C, Andrikou K, Martini S, Iorio GC, Scartozzi M, Mistrangelo M, Fornaro L, Cassoni P, Cascinu S, Ricardi U, Casadei Gardini A.

Radiat Oncol. 2018 May 2;13(1):83. doi: 10.1186/s13014-018-1035-9.

17.

Analysis of Early and Long-Term Oncologic Outcomes After Converted Laparoscopic Resection Compared to Primary Open Surgery for Rectal Cancer.

Allaix ME, Furnée E, Esposito L, Mistrangelo M, Rebecchi F, Arezzo A, Morino M.

World J Surg. 2018 Oct;42(10):3405-3414. doi: 10.1007/s00268-018-4614-x.

PMID:
29610930
18.

Different quality of treatment in retroperitoneal sarcomas (RPS) according to hospital-case volume and surgeon-case volume: a retrospective regional analysis in Italy.

Sandrucci S, Ponzetti A, Gianotti C, Mussa B, Lista P, Grignani G, Mistrangelo M, Bertetto O, Di Cuonzo D, Ciccone G.

Clin Sarcoma Res. 2018 Feb 28;8:3. doi: 10.1186/s13569-018-0091-0. eCollection 2018.

19.

Current treatments for anal condylomata acuminata.

Mistrangelo M, Dal Conte I, Volpatto S, DI Benedetto G, Testa V, Currado F, Morino M.

Minerva Chir. 2018 Feb;73(1):100-106. doi: 10.23736/S0026-4733.17.07554-X. Epub 2017 Nov 20. Review.

PMID:
29154519
20.

The continuing training program of oncology network of Piemonte and Valle d'Aosta: a model for improving the management of oncologic patients.

Viale M, Mistrangelo M, Caristo T, Carobene A, Grietti E, Pezzin M, Bertetto O.

Ann Oncol. 2017 Oct;28 Suppl 6:vi97. doi: 10.1093/annonc/mdx436.013. No abstract available.

21.

The follow-up and lifestyle (FUCSAM project). Oncology Network of Piemonte and Valle d'Aosta: update 2017.

Mistrangelo M, Gallo F, Giordano L, Solerio D, Bau MG, Romaniello I, Pietribiasi F, Pacquola MG, Castiglione F, Sarli F, Monagheddu C, Ceccarelli M, Ciccone G, Mistrangelo M, Viale M, Bertetto O.

Ann Oncol. 2017 Oct;28 Suppl 6:vi80. doi: 10.1093/annonc/mdx433.006. No abstract available.

22.

Image-guided SIB-IMRT for the treatment of anal cancer patients.

Franco P, Arcadipane F, Racca P, Mistrangelo M, Cassoni P, Morino M, Ricardi U.

Ann Oncol. 2017 Oct;28 Suppl 6:vi8. doi: 10.1093/annonc/mdx422.016. No abstract available.

23.

Pancreatic cancer: sharing a nutrition education project with the patients and their care givers.

Satolli MA, Finocchiaro C, Durelli P, Spadi R, Ponzetti A, Monge T, Brossa L, Agnello E, Franco P, Strignano P, Storto S, Mistrangelo M, Viale M, Ciuffreda L, Bertetto O.

Ann Oncol. 2017 Oct;28 Suppl 6:vi51-vi52. doi: 10.1093/annonc/mdx425.027. No abstract available.

24.

The ENDOPREDICT® molecular test for breast cancer prognosis: clinical-pathological correlations and therapeutic implications on a selected cohort of patients.

Castellano I, Metovic J, Balmativola D, Francia Di Celle P, Riera L, Bertetto O, Mistrangelo M, Cassoni P, Marchiò C, Sapino A.

Ann Oncol. 2017 Oct;28 Suppl 6:vi36-vi37. doi: 10.1093/annonc/mdx424.041. No abstract available.

25.

Start (active surveillance or radical treatment for newly diagnosed patients with a localized, low risk, prostate cancer): an epidemiological study of the Oncology Network of Piemonte and Valle d'Aosta. Update 2017.

Galassi C, Ceccarelli M, Monagheddu C, Pagano E, Rosato R, Ivaldi P, Bollito E, Zitella A, De Luca S, Camilli M, Munoz F, Bellissimo AR, Bongiovanni F, Ponti di Sant'Angelo F, Mistrangelo M, Ciccone G, Bertetto O.

Ann Oncol. 2017 Oct;28 Suppl 6:vi20-vi21. doi: 10.1093/annonc/mdx423.012. No abstract available.

26.

Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer.

Arcadipane F, Franco P, Ceccarelli M, Furfaro G, Rondi N, Trino E, Martini S, Iorio GC, Mistrangelo M, Cassoni P, Racca P, Morino M, Ricardi U.

Asia Pac J Clin Oncol. 2018 Jun;14(3):217-223. doi: 10.1111/ajco.12768. Epub 2017 Aug 30.

PMID:
28856848
27.

Hematologic toxicity in anal cancer patients during combined chemo-radiation: a radiation oncologist perspective.

Franco P, Arcadipane F, Ragona R, Mistrangelo M, Cassoni P, Racca P, Morino M, Numico G, Ricardi U.

Expert Rev Anticancer Ther. 2017 Apr;17(4):335-345. doi: 10.1080/14737140.2017.1288104. Epub 2017 Feb 17. Review.

PMID:
28277103
28.

Lumbar-sacral bone marrow dose modeling for acute hematological toxicity in anal cancer patients treated with concurrent chemo-radiation.

Franco P, Ragona R, Arcadipane F, Mistrangelo M, Cassoni P, Rondi N, Morino M, Racca P, Ricardi U.

Med Oncol. 2016 Dec;33(12):137. Epub 2016 Nov 4.

PMID:
27815805
29.

Perineal stapled prolapse resection for full-thickness external rectal prolapse: a multicentre prospective study.

Mistrangelo M, Tonello P, Brachet Contul R, Arnone G, Passera R, Grasso L, Rapetti L, Borroni R, Pozzo M, Roveroni M, Morino M, Perinotti R.

Colorectal Dis. 2016 Nov;18(11):1094-1100. doi: 10.1111/codi.13328.

PMID:
26969880
30.

Is Ovarian Cancer Being Managed According to Clinical Guidelines? Evidence From a Population-Based Clinical Audit.

Sobrero S, Pagano E, Piovano E, Bono L, Ceccarelli M, Ferrero A, Macchi C, Mistrangelo M, Patriarca S, Tripodi E, Zanetti R, Bertetto O, Ciccone G, Zola P.

Int J Gynecol Cancer. 2016 Nov;26(9):1615-1623.

PMID:
27779546
31.

Conversion of laparoscopic colorectal resection for cancer: What is the impact on short-term outcomes and survival?

Allaix ME, Furnée EJ, Mistrangelo M, Arezzo A, Morino M.

World J Gastroenterol. 2016 Oct 7;22(37):8304-8313. Review.

32.

The Thunderbeat and Other Energy Devices in Laparoscopic Colorectal Resections: Analysis of Outcomes and Costs.

Allaix ME, Arezzo A, Giraudo G, Arolfo S, Mistrangelo M, Morino M.

J Laparoendosc Adv Surg Tech A. 2017 Dec;27(12):1225-1229. doi: 10.1089/lap.2016.0317. Epub 2016 Jul 15.

33.

Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients.

Franco P, Arcadipane F, Ragona R, Lesca A, Gallio E, Mistrangelo M, Cassoni P, Arena V, Bustreo S, Faletti R, Rondi N, Morino M, Ricardi U.

Med Oncol. 2016 Jul;33(7):72. doi: 10.1007/s12032-016-0789-x. Epub 2016 Jun 8.

PMID:
27277756
34.

Locally Advanced (T3-T4 or N+) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.

Franco P, Arcadipane F, Ragona R, Mistrangelo M, Cassoni P, Rondi N, Morino M, Racca P, Ricardi U.

Anticancer Res. 2016 Apr;36(4):2027-32.

35.

Early-stage Node-negative (T1-T2N0) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.

Franco P, Arcadipane F, Ragona R, Mistrangelo M, Cassoni P, Rondi N, Morino M, Racca P, Ricardi U.

Anticancer Res. 2016 Apr;36(4):1943-8.

36.

Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer.

Franco P, Ragona R, Arcadipane F, Mistrangelo M, Cassoni P, Rondi N, Morino M, Racca P, Ricardi U.

Clin Transl Oncol. 2017 Jan;19(1):67-75. doi: 10.1007/s12094-016-1504-2. Epub 2016 Apr 1.

PMID:
27037814
37.

Energy Sources for Laparoscopic Colorectal Surgery: Is One Better than the Others?

Allaix ME, Furnée EJ, Arezzo A, Mistrangelo M, Morino M.

J Laparoendosc Adv Surg Tech A. 2016 Apr;26(4):264-9. doi: 10.1089/lap.2016.0076. Epub 2016 Mar 17. Review.

PMID:
26986017
38.

Volumetric modulated arc therapy (VMAT) in the combined modality treatment of anal cancer patients.

Franco P, Arcadipane F, Ragona R, Mistrangelo M, Cassoni P, Munoz F, Rondi N, Morino M, Racca P, Ricardi U.

Br J Radiol. 2016;89(1060):20150832. doi: 10.1259/bjr.20150832. Epub 2016 Feb 3.

39.

Erratum to: Evaluation and management of hemorrhoids: Italian society of colorectal surgery (SICCR) consensus statement.

Trompetto M, Clerico G, Cocorullo GF, Giordano P, Marino F, Martellucci J, Milito G, Mistrangelo M, Ratto C.

Tech Coloproctol. 2016 Mar;20(3):201. doi: 10.1007/s10151-015-1416-0. No abstract available.

PMID:
26728606
40.

Lymphogranuloma venereum in North-West Italy, 2009-2014.

Dal Conte I, Mistrangelo M, Gregori G, Pasqualini C.

Sex Transm Infect. 2015 Nov;91(7):472. doi: 10.1136/sextrans-2015-052178. No abstract available.

PMID:
26487773
41.

Evaluation and management of hemorrhoids: Italian society of colorectal surgery (SICCR) consensus statement.

Trompetto M, Clerico G, Cocorullo GF, Giordano P, Marino F, Martellucci J, Milito G, Mistrangelo M, Ratto C.

Tech Coloproctol. 2015 Oct;19(10):567-75. doi: 10.1007/s10151-015-1371-9. Epub 2015 Sep 24. Erratum in: Tech Coloproctol. 2016 Mar;20(3):201.

PMID:
26403234
42.

Topical application of LEVORAG® as first-line treatment for chronic anal fissures: a preliminary multicentric study.

Giordano P, Mistrangelo M, Cracco N, D'Elia A, Creperio G, Digito F, Paduano R, Tapparo A, Quinto S, Villa E, Pagano C.

Minerva Chir. 2015 Oct;70(5):319-25. Epub 2015 May 27.

43.

Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.

Franco P, Mistrangelo M, Arcadipane F, Munoz F, Sciacero P, Spadi R, Migliaccio F, Angelini V, Bombaci S, Rondi N, Numico G, Ragona R, Cassoni P, Morino M, Racca P, Ricardi U.

Cancer Invest. 2015 Jul;33(6):259-66. doi: 10.3109/07357907.2015.1028586. Epub 2015 May 7.

44.

YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study.

Senetta R, Duregon E, Sonetto C, Spadi R, Mistrangelo M, Racca P, Chiusa L, Munoz FH, Ricardi U, Arezzo A, Cassenti A, Castellano I, Papotti M, Morino M, Risio M, Cassoni P.

PLoS One. 2015 Apr 15;10(4):e0123759. doi: 10.1371/journal.pone.0123759. eCollection 2015.

45.

Comments on stapled anopexy and STARR in surgical treatment of haemorrhoidal disease.

Mistrangelo M, Ghiglione F, Tonello P.

Updates Surg. 2014 Dec;66(4):289-90. doi: 10.1007/s13304-014-0272-1. Epub 2014 Nov 16. No abstract available.

PMID:
25399305
46.

Laparoscopic versus open resection for transverse colon cancer.

Mistrangelo M, Allaix ME, Cassoni P, Giraudo G, Arolfo S, Morino M.

Surg Endosc. 2015 Aug;29(8):2196-202. doi: 10.1007/s00464-014-3921-z. Epub 2014 Oct 11.

PMID:
25303924
47.

Laparoscopic versus open resection for colon cancer: 10-year outcomes of a prospective clinical trial.

Allaix ME, Giraudo G, Mistrangelo M, Arezzo A, Morino M.

Surg Endosc. 2015 Apr;29(4):916-24. doi: 10.1007/s00464-014-3752-y. Epub 2014 Aug 9.

48.

Lymphogranuloma venereum: an old, forgotten re-emerging systemic disease.

Dal Conte I, Mistrangelo M, Cariti C, Chiriotto M, Lucchini A, Vigna M, Morino M, Di Perri G.

Panminerva Med. 2014 Mar;56(1):73-83. Epub 2014 Feb 11. Review.

PMID:
24518282
49.

Comments on Levic et al.: The outcome of rectal cancer after early salvage TME following TEM compared with primary TME: a case-matched study.

Mistrangelo M, Allaix ME, Arezzo A, Morino M.

Tech Coloproctol. 2014 Jan;18(1):81. doi: 10.1007/s10151-013-1084-x. Epub 2013 Nov 1. No abstract available.

PMID:
24178947
50.

Comments on decision analysis for patients with T1 adenocarcinoma of the low rectum.

Mistrangelo M, Arezzo A, Morino M.

Dis Colon Rectum. 2013 Oct;56(10):e396-7. doi: 10.1097/DCR.0b013e31829f3da8. No abstract available.

PMID:
24022540

Supplemental Content

Loading ...
Support Center